Unlimited Innovations launches CERECONS Health IT product suite for Coast Healthcare Management
Leading provider of IT solutions for healthcare industry Unlimited Innovations has implemented and launched its CERECONS Health IT product suite for Coast Healthcare Management.
The innovative cloud-based software CERECONS’ provides Coast with powerful clinical decision support and population management tools to help them deliver quality, efficient care while automating administrative tasks and enable patient access to medical records including lab and medication history.
Philip Paul, President of Unlimited Innovations said, “The CERECONS product suite gives Coast Healthcare Management the tools and solutions they need to continue their impressive growth in total membership, while empowering their administrators to benefit from the operational efficiencies and clinical insight gained through CERECONS.”
Simon Brandon, Director of Information Systems for Coast Healthcare Management said, “We searched for a Health IT partner with a proven care collaboration solution that could help us integrate several of our existing IT systems and displace a number of other tools that did not meet our workflow efficiency and clinical insight objectives. The solution also had to meet critical deployment deadlines within a matter of weeks of project start. We project with CERECONS because of their strong commitment to deliver.” Mr. Brandon also said, “We are very pleased with our selection of CERECONS, and are grateful to them for keeping their delivery commitments.” He also added, “They are among the most professional and productive firms we’ve had the pleasure of working with.”
CERECONS is a private cloud-based platform for care coordination and patient engagement that leverages community-based Electronic Health Records to deliver clinical decision support at the point-of-care and also gives patients access to their healthcare information.
Introducing Dosis - the AI powered dosing platform
Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works.
When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing.
The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced.
What is the Strategic Anemia Advisor?
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease.
SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool.
What else is Dosis working on?
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs.
What are Dosis' strategic goals for the next 2-3 years?
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.
What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.